Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
63.06 USD | -1.11% | -7.17% | +14.56% |
May. 16 | Ani Pharmaceuticals Insider Sold Shares Worth $1,101,821, According to a Recent SEC Filing | MT |
May. 10 | ANI Pharmaceuticals Seeks M&A | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.56% | 1.24B | |
+32.79% | 694B | |
+29.18% | 593B | |
-1.52% | 371B | |
+19.79% | 331B | |
+6.58% | 290B | |
+14.08% | 239B | |
-3.11% | 209B | |
+9.96% | 209B | |
+8.05% | 169B |
- Stock Market
- Equities
- ANIP Stock
- News ANI Pharmaceuticals, Inc.
- Guggenheim Adjusts Price Target on ANIP to $59 From $55, Maintains Buy Rating